Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Xiaoming Dai, Ph.D.

Concepts (115)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Xiaoming Dai's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Xiaoming Dai has written about over time.
Embryo, Nonmammalian, 1 publications between 2013 and 2013, average publication date October 2013. Phosphoproteins, 4 publications between 2015 and 2018, average publication date February 2017. Adaptor Proteins, Signal Transducing, 5 publications between 2015 and 2022, average publication date February 2018. Carcinoma, Hepatocellular, 2 publications between 2017 and 2020, average publication date November 2018. Endopeptidases, 1 publications between 2020 and 2020, average publication date July 2020. Von Hippel-Lindau Tumor Suppressor Protein, 1 publications between 2020 and 2020, average publication date July 2020. Proto-Oncogene Proteins c-akt, 3 publications between 2021 and 2022, average publication date December 2021. AMP-Activated Protein Kinases, 3 publications between 2021 and 2023, average publication date August 2022. TOR Serine-Threonine Kinases, 3 publications between 2022 and 2023, average publication date September 2022. Multiprotein Complexes, 2 publications between 2022 and 2023, average publication date January 2023. Anaphase, 1 publications between 2023 and 2023, average publication date May 2023. Lactic Acid, 1 publications between 2023 and 2023, average publication date May 2023.

To see the data from this visualization as text, click here.
Dai's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (115)
Explore
_
Co-Authors (24)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.